Secondary GBMs evolve from diffuse astrocytomas and have frequent TP53 and ATRX mutations (Ohgaki and Kleihues, 2013; Marker et al., 2021) which are also commonly observed in IDH-mutant astrocytomas (Mirchia and Richardson, 2020). This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).